Notch Signaling News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Notch signaling. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Notch Signaling Today - Breaking & Trending Today

New treatment approach shows promise in reversing hormone resistance in breast cancer

A collaborative study between LSU Health New Orleans School of Medicine, the University of Rochester and Cellestia Biotech AG, a biopharmaceutical company headquartered in Basel, Switzerland, provides compelling evidence that combining an investigational oral drug with standard-of-care medications reverts hormone resistance and increases Rx effectiveness in experimental models of estrogen-receptor positive (ER+) and triple-negative breast cancers (TNBC), respectively. ....

United States , Jovanny Zabaleta , Giulia Monticone , Fokhrul Hossain , Luis Del Valle , Samarpan Majumder , Dorota Wyczechowska , Danielle Ellis , Lucio Miele , University Of Rochester , Health New Orleans School Of Medicine , Health New Orleans , New Orleans School , Cellestia Biotech , Senior Author , Assistant Dean , Translational Science , Assistant Professor , African American , New Orleans , Luis Del , Cancer Crusaders Chair , Breast Cancer , Notch Signaling ,

Experimental antibody treatment shows promise for preventing bone marrow transplant complication

An experimental antibody treatment largely prevented a bone marrow transplant complication called graft versus host disease (GVHD) in the intestines, without causing broad immune suppression, in a preclinical study led by researchers from Penn Medicine and Dana-Farber/Boston Children's Cancer and Blood Disorders Center and published today in Science Translational Medicine. ....

United States , Lily Ramsey , Eric Perkey , Ashley Vanderbeck , Leslies Kean , Ivan Maillard , Regeneron Inc , Perelman School Of Medicine , Be The Match Foundation , University Of Michigan , Leukemia Lymphoma Society , Blood Disorders Center , Pediatrics At Harvard Medical School , University Of Pennsylvania , National Institutes Of Health , Amy Strelzer Manasevit Research Program , Penn Medicine , Boston Children , Science Translational , Perelman School , Harvard Medical School , Pediatric Stem Cell Transplant , Victor Tkachev Phd , Mass General Brigham , Boston Childrens , Lymphoma Society ,

Incurable liver disease could be reversed with a single drug

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the liver, could be reversed with a single drug. ....

Chengjian Zhao , Sanford Burnham Preby , Roberta Smith , Emily Henderson , Proceedings Of The National Academy Sciences , Alagille Syndrome Alliance , Associate Professor Duc Dong , National Academy , Alagille Syndrome , Industry Focus , Alagille Syndrome , Genetic Disorder , Notch Signaling , Rare Disease ,